International Review of Cell and Molecular Biology
| 短名 | Int. Rev. Cell. Mol. Biol. |
| 期刊索引 | 中科院 3 区 |
| ISSN | 1937-6448 |
| 国内分区 | 生物学(3区)生物学生化与分子生物学(3区)生物学细胞生物学(3区) |
International Review of Cell and Molecular Biology presents current advances and comprehensive reviews in cell biology-both plant and animal. Articles address structure and control of gene expression, nucleocytoplasmic interactions, control of cell development and differentiation, and cell transformation and growth. Authored by some of the foremost scientists in the field, each volume provides up-to-date information and directions for future research.
期刊主页| 涉及主题 | 生物遗传学化学生物化学细胞生物学医学内科学基因计算生物学 |
| 出版信息 | 出版商: Elsevier Inc.，出版周期: Irregular，期刊类型: book-series |
| 基本数据 | 创刊年份: 2008，原创研究文献占比: 0.00%，自引率:N.A.， Gold OA占比: 0.00% |
| 平均审稿周期 | 网友分享经验：>12周，或约稿 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Copyright
2024-1-1
Contributors
2024-1-1
Circuits involving the hypothalamic suprachiasmatic nucleus for controlling diverse physiologies verified by the aid of optogenetics and chemogenetics
2024-1-1
Series Page
2024-1-1
Copyright
2024-1-1
Chemokine receptors in primary and secondary lymphoid tissues
2024-1-1
Half Title Page
2024-1-1
Copyright
2024-1-1
Contributors
2024-1-1
Copyright
2024-1-1
Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes
2024-1-1
Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis
2024-1-1
Next-generation deconvolution of transcriptomic data to investigate the tumor microenvironment
2024-1-1
Advances in metastatic prostate cancer circulating tumor cell enrichment technologies and clinical studies
2024-1-1
Inflammatory breast cancer: Epidemiologic data and therapeutic results
2024-1-1
Chemokine receptors in COVID-19 infection
2024-1-1
Role of chemokine receptors in transplant rejection and graft-versus-host disease
2024-1-1
Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors
2024-1-1
Emerging trends in gastrointestinal cancers: Targeting developmental pathways in carcinogenesis and tumor progression
2024-1-1
Non-rhythmic modulators of the circadian system: A new class of circadian modulators
2024-1-1
Copyright
2024-1-1
Title Page
2024-1-1
Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients
2024-1-1
Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency
2024-1-1
Therapeutic potential of hedgehog signaling in advanced cancer types
2024-1-1
Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance
2024-1-1
Multifaceted perspectives of detecting and targeting solid tumors
2024-1-1
Epigenetics and CTCs: New biomarkers and impact on tumor biology
2024-1-1
An Overview of the Unfolded Protein Response (UPR) and Autophagy Pathways in Human Viral Oncogenesis
2024-1-1
Half Title Page
2024-1-1
Title Page
2024-1-1
Contributors
2024-1-1
Importance of targeting various cell signaling pathways in solid cancers
2024-1-1
Deciphering the molecular biology of inflammatory breast cancer through molecular characterization of patient samples and preclinical models
2024-1-1
Inflammatory breast cancer biomarkers and biology
2024-1-1
Preface
2024-1-1
Epigenetic contribution to the relationship between obesity and cancer
2024-1-1
Epigenetic contributions to cancer: Exploring the role of glycation reactions
2024-1-1
Liver as a nexus of daily metabolic cross talk
2024-1-1
Epigenetic regulation of cancer
2024-1-1
Regulation of lipid and serine metabolism by the oncogene c-Myc
2024-1-1
Epigenetic orchestration of the DNA damage response: Insights into the regulatory mechanisms
2024-1-1
Epigenetic regulation in ovarian cancer
2024-1-1
Epigenetic contribution to cancer
2024-1-1
Epigenetic alterations in AML: Deregulated functions leading to new therapeutic options
2024-1-1
Title Page
2024-1-1
Half Title Page
2024-1-1
Contributors
2024-1-1
Contributors
2024-1-1
Half Title Page
2024-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远